Cargando…

Physiologically-Based Pharmacokinetics Modeling for Hydroxychloroquine as a Treatment for Malaria and Optimized Dosing Regimens for Different Populations

Malaria is a severe parasite infectious disease with high fatality. As one of the approved treatments of this disease, hydroxychloroquine (HCQ) lacks clinical administration guidelines for patients with special health conditions and co-morbidities. This may result in improper dosing for different po...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhai, Jingchen, Ji, Beihong, Cai, Lianjin, Liu, Shuhan, Sun, Yuchen, Wang, Junmei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144775/ https://www.ncbi.nlm.nih.gov/pubmed/35629219 http://dx.doi.org/10.3390/jpm12050796

Ejemplares similares

Phosphorylation at Ser289 Enhances the Oligomerization of Tau Repeat R2
por: Man, Viet Hoang, et al.
Publicado: (2023)

Incorporating structural similarity into a scoring function to enhance the prediction of binding affinities
por: Ji, Beihong, et al.
Publicado: (2021)

Prediction of Drug–Drug Interactions Between Opioids and Overdosed Benzodiazepines Using Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation
por: Ji, Beihong, et al.
Publicado: (2019)

Population Pharmacokinetics of Hydroxychloroquine in COVID-19 Patients: Implications for Dose Optimization
por: Thémans, Pauline, et al.
Publicado: (2020)

Population pharmacokinetics and optimization of the dosing regimen of digoxin in adult patients
por: Komatsu, Toshiaki, et al.
Publicado: (2015)

Population Pharmacokinetics and Dosing Regimen Optimization of Latamoxef in Chinese Children
por: Wang, Yang, et al.
Publicado: (2022)

In silico binding profile characterization of SARS-CoV-2 spike protein and its mutants bound to human ACE2 receptor
por: Zhang, Yuzhao, et al.
Publicado: (2021)

Development of a Physiologically Based Pharmacokinetic Model for Hydroxychloroquine and Its Application in Dose Optimization in Specific COVID-19 Patients
por: Zhang, Miao, et al.
Publicado: (2021)

Population pharmacokinetic analysis and dosing regimen optimization of penicillin G in patients with infective endocarditis
por: Komatsu, Toshiaki, et al.
Publicado: (2016)

Population pharmacokinetic analysis and dosing regimen optimization of teicoplanin in critically ill patients with sepsis
por: Chen, Chao‐Yang, et al.
Publicado: (2023)

Evaluation of Amikacin Pharmacokinetics and Pharmacodynamics for Optimal Initial Dosing Regimen
por: Kato, Hideo, et al.
Publicado: (2017)

Physiologically based pharmacokinetic modeling for dose optimization of quinine–phenobarbital coadministration in patients with cerebral malaria
por: Sae‐heng, Teerachat, et al.
Publicado: (2021)

Population Pharmacokinetics of Intramuscular Artesunate in African Children With Severe Malaria: Implications for a Practical Dosing Regimen
por: Hendriksen, ICE, et al.
Publicado: (2013)

Hydroxychloroquine for prophylaxis in COVID-19: Need to revisit dosing regimen
por: Pareek, Anil, et al.
Publicado: (2020)

Predicting Hydroxychloroquine Clearance in Healthy and Diseased Populations Using a Physiologically Based Pharmacokinetic Approach
por: Alqahtani, Faleh, et al.
Publicado: (2023)

A physiologically based pharmacokinetic model to optimize the dosage regimen and withdrawal time of cefquinome in pigs
por: Mi, Kun, et al.
Publicado: (2023)

Population pharmacokinetics and pharmacodynamics of hydroxyurea in sickle cell anemia patients, a basis for optimizing the dosing regimen
por: Paule, Ines, et al.
Publicado: (2011)

Population Pharmacokinetics and Dosing Regimen Optimization of Meropenem in Cerebrospinal Fluid and Plasma in Patients with Meningitis after Neurosurgery
por: Lu, Cheng, et al.
Publicado: (2016)

Implementation of a Physiologically Based Pharmacokinetic Modeling Approach to Guide Optimal Dosing Regimens for Imatinib and Potential Drug Interactions in Paediatrics
por: Adiwidjaja, Jeffry, et al.
Publicado: (2020)

Pharmacokinetics and pharmacodynamics of levofloxacin injection in healthy Chinese volunteers and dosing regimen optimization
por: Cao, G, et al.
Publicado: (2013)

Population Pharmacokinetics Analysis of Amikacin Initial Dosing Regimen in Elderly Patients
por: Kato, Hideo, et al.
Publicado: (2021)

Population Pharmacokinetics and Dosing Regimen of Lithium in Chinese Patients With Bipolar Disorder
por: Jin, Zi-bin, et al.
Publicado: (2022)

Optimization of flucloxacillin dosing regimens in critically ill patients using population pharmacokinetic modelling of total and unbound concentrations
por: Jager, Nynke G L, et al.
Publicado: (2020)

Optimization of Busulfan Dosing Regimen in Pediatric Patients Using a Population Pharmacokinetic Model Incorporating GST Mutations
por: Yuan, Jinjie, et al.
Publicado: (2021)

Population pharmacokinetics and dosing optimization of cefathiamidine in children with hematologic infection
por: Zhi, Li-Juan, et al.
Publicado: (2018)

Physiologically Based Pharmacokinetic Modeling for Selumetinib to Evaluate Drug‐Drug Interactions and Pediatric Dose Regimens
por: Cohen‐Rabbie, Sarit, et al.
Publicado: (2021)

A linked physiologically based pharmacokinetic model for hydroxychloroquine and metabolite desethylhydroxychloroquine in SARS‐CoV‐2(−)/(+) populations
por: Steinbronn, Claire, et al.
Publicado: (2023)

Population pharmacokinetics of piperacillin in febrile children receiving cancer chemotherapy: the impact of body weight and target on an optimal dosing regimen
por: Thorsted, Anders, et al.
Publicado: (2019)

Impact of Dose Delays and Alternative Dosing Regimens on Pertuzumab Pharmacokinetics
por: Liu, Stephanie N., et al.
Publicado: (2021)

Population pharmacokinetics and dose optimization of vancomycin in neonates
por: Lee, Soon Min, et al.
Publicado: (2021)

Population Pharmacokinetics of Hydroxychloroquine and 3 Metabolites in COVID-19 Patients and Pharmacokinetic/Pharmacodynamic Application
por: Alvarez, Jean Claude, et al.
Publicado: (2022)

Physiologically-based pharmacokinetic modeling for single and multiple dosing regimens of ceftriaxone in healthy and chronic kidney disease populations: a tool for model-informed precision dosing
por: Alasmari, Fawaz, et al.
Publicado: (2023)

Identifying an optimal dihydroartemisinin-piperaquine dosing regimen for malaria prevention in young Ugandan children
por: Wallender, Erika, et al.
Publicado: (2021)

Optimal Teicoplanin Dosage Regimens in Critically Ill Patients: Population Pharmacokinetics and Dosing Simulations Based on Renal Function and Infection Type
por: Wang, Yifan, et al.
Publicado: (2023)

Fast, Accurate, and Reliable Protocols for Routine Calculations of Protein–Ligand Binding Affinities in Drug Design Projects Using AMBER GPU-TI with ff14SB/GAFF
por: He, Xibing, et al.
Publicado: (2020)

Population Pharmacokinetic Modeling and Dose Optimization of Vancomycin in Chinese Patients with Augmented Renal Clearance
por: Zhao, Sixuan, et al.
Publicado: (2021)

Hydroxychloroquine: From Malaria to Autoimmunity
por: Ben-Zvi, Ilan, et al.
Publicado: (2011)

Application of a Physiologically Based Pharmacokinetic Model to Characterize Time-dependent Metabolism of Voriconazole in Children and Support Dose Optimization
por: Zhang, Yahui, et al.
Publicado: (2021)

Optimization and Validation of Dosage Regimen for Ceftiofur against Pasteurella multocida in Swine by Physiological Based Pharmacokinetic–Pharmacodynamic Model
por: Mi, Kun, et al.
Publicado: (2022)

Optimization of Initial Dose Regimen for Sirolimus in Pediatric Patients With Lymphangioma
por: Chen, Xiao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ncf4leodb966i314dnrgsof297